Search

everythinglearnresearchcommunity

for

Search:↓

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Blocking casein kinase 1 in skin cells can help melanocyte precursors move better, potentially helping with conditions like vitiligo or gray hair.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

ALRN-6924 may prevent hair loss caused by chemotherapy.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Suppressing eIF4E can prevent hair loss from chemotherapy.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

The treatment was ineffective in humans.

Suppressing ODC activity reduces tumor growth in hair follicles.

K6/ODC transgenic mice are effective for quickly identifying cancer-causing chemicals.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

QLT0267 stops hair follicle cell growth and movement.

Cancer treatments often cause skin, nail, and hair problems.

Polyamines are crucial for skin tumor development, and inhibiting them can prevent tumors.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

The drug combination was safe and showed promise in treating advanced tumors.

Axitinib treatment turned a man's grey hair back to black.

Antizyme slows skin tumor growth by reducing cell growth in mice.

Compound 4 is a promising treatment for hair loss with low toxicity.

Increasing PDCD4 protein may help prevent or treat some skin cancers.

Blocking mTORC1 reduces skin tumor growth in mice.